Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells
2011 · Proceedings of the National Academy of Sciences · 489 citations
https://doi.org/10.1073/pnas.1017667108
K
Kirsten L. Bryant
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
198
Papers
3.5K
Citations
20
h-index
24
i10-index
Kirsten L. Bryant is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Advanced Breast Cancer Therapies & Colorectal Cancer Treatments and Studies. The author has an h-index of 20, co-authored 169 publications.
ORCID: 0000-0003-4026-0942Papers by this author
worksKRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism
2018 · Cancer Cell · 186 citations
https://doi.org/10.1016/j.ccell.2018.10.001
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
2024 · Science · 91 citations
https://doi.org/10.1126/science.adk0775
KRAS-dependent cancer cells promote survival by producing exosomes enriched in Survivin
2021 · Cancer Letters · 45 citations
https://doi.org/10.1016/j.canlet.2021.05.031
A novel fluorescence-based biosynthetic trafficking method provides pharmacologic evidence that PI4-kinase IIIα is important for protein trafficking from the endoplasmic reticulum to the plasma membrane
2015 · BMC Cell Biology · 8 citations
https://doi.org/10.1186/s12860-015-0049-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat